Pfizer immuno-oncology drug wins U.S. approval for bladder cancer | | (Reuters) - U.S. health regulators on Tuesday granted accelerated approval for Pfizer Inc's immuno-oncology drug Bavencio to treat advanced bladder cancer, marking the second approval in less than two months for the treatment developed along with Germany's Merck KGaA. |
| |
Bullied teens more likely to smoke, drink and use drugs | | (Reuters Health) - Children who are bullied in fifth grade are more likely to become depressed and experiment with drugs and alcohol during their teen years than their peers who weren’t victimized by other kids, a U.S. study suggests. |
| |
| | |